Annual Revenue
$63.91 M
-$543.00 K-0.84%
December 31, 2023
Summary
- As of February 22, 2025, CDTX annual revenue is $63.91 million, with the most recent change of -$543.00 thousand (-0.84%) on December 31, 2023.
- During the last 3 years, CDTX annual revenue has risen by +$51.84 million (+429.58%).
- CDTX annual revenue is now -0.84% below its all-time high of $64.45 million, reached on December 31, 2022.
Performance
CDTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- CDTX quarterly revenue is not available.
Performance
CDTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- CDTX TTM revenue is not available.
Performance
CDTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CDTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.8% | - | - |
| 3 y3 years | +429.6% | - | - |
| 5 y5 years | - | - | - |
CDTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.8% | +28.9% | ||||
| 5 y | 5-year | -0.8% | +429.6% | ||||
| alltime | all time | -0.8% | +429.6% |
Cidara Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $302.00 K(-96.4%) | $61.36 M(-7.2%) |
| Mar 2024 | - | $8.46 M(-80.5%) | $66.15 M(-21.1%) |
| Dec 2023 | $63.91 M(-0.8%) | $43.38 M(+370.6%) | $83.79 M(+65.0%) |
| Sep 2023 | - | $9.22 M(+81.1%) | $50.79 M(-38.3%) |
| Jun 2023 | - | $5.09 M(-80.5%) | $82.32 M(-1.3%) |
| Mar 2023 | - | $26.11 M(+151.5%) | $83.45 M(+29.5%) |
| Dec 2022 | $64.45 M(+30.0%) | $10.38 M(-74.5%) | $64.45 M(+5.1%) |
| Sep 2022 | - | $40.74 M(+555.5%) | $61.29 M(+121.9%) |
| Jun 2022 | - | $6.22 M(-12.6%) | $27.63 M(-49.1%) |
| Mar 2022 | - | $7.11 M(-1.6%) | $54.27 M(+9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $49.57 M(+310.8%) | $7.22 M(+2.1%) | $49.57 M(+7.6%) |
| Sep 2021 | - | $7.08 M(-78.5%) | $46.08 M(+11.3%) |
| Jun 2021 | - | $32.86 M(+1264.7%) | $41.42 M(+246.7%) |
| Mar 2021 | - | $2.41 M(-35.4%) | $11.95 M(-1.0%) |
| Dec 2020 | $12.07 M(-42.3%) | $3.73 M(+54.3%) | $12.07 M(+18.9%) |
| Sep 2020 | - | $2.42 M(-28.8%) | $10.15 M(-62.2%) |
| Jun 2020 | - | $3.39 M(+34.1%) | $26.84 M(+14.5%) |
| Mar 2020 | - | $2.53 M(+39.4%) | $23.45 M(+12.1%) |
| Dec 2019 | $20.91 M | $1.81 M(-90.5%) | $20.91 M(+9.5%) |
| Sep 2019 | - | $19.10 M | $19.10 M |
FAQ
- What is Cidara Therapeutics annual revenue?
- What is the all time high annual revenue for Cidara Therapeutics?
- What is Cidara Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Cidara Therapeutics?
- What is the all time high TTM revenue for Cidara Therapeutics?
What is Cidara Therapeutics annual revenue?
The current annual revenue of CDTX is $63.91 M
What is the all time high annual revenue for Cidara Therapeutics?
Cidara Therapeutics all-time high annual revenue is $64.45 M
What is Cidara Therapeutics annual revenue year-on-year change?
Over the past year, CDTX annual revenue has changed by -$543.00 K (-0.84%)
What is the all time high quarterly revenue for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly revenue is $43.38 M
What is the all time high TTM revenue for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM revenue is $83.79 M